PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective Study.
Mifen ChenZhenghang WangZimin LiuTing DengXiaodong WangZhiwei ChangQi ZhangWenlei YangNing LiuZhi JiXiaotian ZhangXicheng WangZhi PengYi LiYujuan CaoXuan JinHongxia LuHuajun QuYong TangChunlei XuWeijia FangHangyu ZhangDong YanLi WangJiayi LiJingdong ZhangQiwei WangLiying XueFei YinGuangjie HanZhiqiang ChengQing LiuYongdong JinYinjie ZhangLanxing LiBaoshan CaoYanhong YaoZhiyu ChenJianling ZouJieer YingQing WeiTiantian TianWeifeng ZhaoLongmei LiTong ZhangFanghua SongYa-Er BaNa LiHui GaoYinghua JiLiying BaoXiaochen ZhaoJinping CaiZheping YuanLin ShenJian LiPublished in: JCO precision oncology (2023)
Chemo-anti-PD-1/PD-L1 is superior to anti-PD-1/PD-L1 in MSI/dMMR gastrointestinal cancers with improved efficacy.